Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR003107)
National Institute on Drug Abuse (K23DA048162, T32DA022981)
Article History
Received: 21 November 2023
Accepted: 15 March 2024
First Online: 13 April 2024
Declarations
:
: This study was approved by the Institutional Review Board at the University of Arkansas for Medical Sciences under protocol 260,265. Given the study design (retrospective chart review), the need for consent was waived.
: Not applicable.
: The author(s) declare that they have no known competing interests that could have appeared to influence the work reported in this paper.